Open AccessAtherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low‐Density Lipoprotein Cholesterol
Author(s) -
Lawler Patrick R.,
Akinkuolie Akintunde O.,
Chu Audrey Y.,
Shah Svati H.,
Kraus William E.,
Craig Damian,
Padmanabhan Latha,
Glynn Robert J.,
Ridker Paul M,
Chasman Daniel I.,
Mora Samia
Publication year - 2017
Publication title -
journal of the american heart association
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.494
H-Index - 85
ISSN - 2047-9980
DOI - 10.1161/jaha.117.005549
Subject(s) - medicine , very low density lipoprotein , lipoprotein , cholesterol , endocrinology , statin , residual risk , hazard ratio , rosuvastatin , population , lipoprotein particle , triglyceride , confidence interval , environmental health
Levels of LDL (low-density lipoprotein) cholesterol in the population are declining, and increasing attention is being focused on residual lipid-related pathways of atherosclerotic cardiovascular disease risk beyond LDL cholesterol. Among individuals with low (<130 mg/dL) LDL cholesterol, we undertook detailed profiling of circulating atherogenic lipoproteins in relation to incident cardiovascular disease in 2 populations.